Fundraising FoxTrelegy Ellipta
1 known investors
Find your way into Trelegy Ellipta
Sign up to see every warm intro you have to Trelegy Ellipta
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Trelegy Ellipta team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
TRELEGY is a once-daily prescription inhaler used long-term to treat COPD (including chronic bronchitis and emphysema) and asthma in adults. It combines an inhaled corticosteroid, an anticholinergic, and a long-acting beta2-adrenergic agonist, and is not intended as a rescue inhaler.
Investors · 1
Frequently asked questions
- What does Trelegy Ellipta do?
- TRELEGY is a once-daily prescription inhaler used long-term to treat COPD (including chronic bronchitis and emphysema) and asthma in adults. It combines an inhaled corticosteroid, an anticholinergic, and a long-acting beta2-adrenergic agonist, and is not intended as a rescue inhaler.
- Who are Trelegy Ellipta's investors?
- Trelegy Ellipta's investors include HEALTHCARE ROYALTY PARTNERS.